CICM examiner reports · fix it Deferring the decision Waiting, reviewing later or handing it on when the case needs you to act now.
What it looks like: The safe-sounding option is often to review in a week, repeat the test, reassure, or refer and let someone else decide. When the patient in front of you needs a decision today, that option loses the marks.
How to fix it: Before you look at the options, decide what you would do in the next hour. Then ask of each option: does this act, or does it put off acting? Pick waiting only when the stem gives you a reason that waiting is safe.
The drill: 15 questions Questions from the Intensive care bank picked because they test this habit. You answer one at a time and see the explanation straight away.
The first 3 are free, below and in the drill with a free account. Any Intensive care plan opens all 15.
Try 3 now. No account needed. Question 1 of 3 Sepsis, microbiology and antimicrobials
A 46-year-old man with smear-positive cavitary pulmonary tuberculosis is in week three of isoniazid, rifampicin, pyrazinamide and ethambutol. He develops nausea and jaundice, with an alanine aminotransferase eight times the upper limit of normal and a bilirubin of 70 micromol/L. Viral serology is negative. What is the most appropriate management? A Continue all four drugs and repeat liver function tests in one week B Stop pyrazinamide and continue isoniazid, rifampicin and ethambutol C Stop isoniazid, rifampicin and pyrazinamide, and start a non-hepatotoxic regimen D Stop all four drugs until liver tests normalise, then restart all four together
Pick an answer to see the explanation. Next question →
Question 1 of 3 · Sepsis, microbiology and antimicrobials
A 46-year-old man with smear-positive cavitary pulmonary tuberculosis is in week three of isoniazid, rifampicin, pyrazinamide and ethambutol. He develops nausea and jaundice, with an alanine aminotransferase eight times the upper limit of normal and a bilirubin of 70 micromol/L. Viral serology is negative. What is the most appropriate management?
Continue all four drugs and repeat liver function tests in one week Stop pyrazinamide and continue isoniazid, rifampicin and ethambutol Stop isoniazid, rifampicin and pyrazinamide, and start a non-hepatotoxic regimen Stop all four drugs until liver tests normalise, then restart all four together Show the answer C. Stop isoniazid, rifampicin and pyrazinamide, and start a non-hepatotoxic regimen
An alanine aminotransferase above three times normal with symptoms or jaundice, or above five times normal without, is the threshold to stop all three potentially hepatotoxic drugs, because isoniazid, rifampicin and pyrazinamide can each cause hepatitis and the culprit cannot be identified from blood tests. Smear-positive cavitary disease is too extensive and infectious to leave untreated while the liver recovers, so an interim non-hepatotoxic regimen, such as ethambutol with a fluoroquinolone and an aminoglycoside, is given. Once the alanine aminotransferase is below about twice normal and bilirubin has normalised, the drugs are reintroduced one at a time with monitoring, usually rifampicin then isoniazid, under specialist supervision. Restarting all four together would not identify the culprit.
Why not A: Continuing all drugs with jaundice and this degree of hepatitis risks fulminant liver failure. Why not B: Isoniazid and rifampicin are also hepatotoxic and must be stopped as well. Why not D: Untreated infectious cavitary disease needs interim cover, and simultaneous reintroduction cannot identify the culprit. Question 2 of 3 · Paediatrics and obstetric critical care
A 3-day-old term baby boy, well at birth, becomes lethargic, feeds poorly and is breathing fast. Blood gas shows respiratory alkalosis, glucose is normal and plasma ammonia is 650 micromol/L. Sepsis treatment has started. What is the most important next step?
Lactulose and neomycin Intravenous sodium bicarbonate Continue feeds and recheck in 6 hours Urgent haemodialysis or haemofiltration Show the answer D. Urgent haemodialysis or haemofiltration
A very high ammonia with respiratory alkalosis in a previously well neonate suggests a urea cycle disorder. Ammonia above about 500 micromol/L, or rising despite medical treatment, needs urgent extracorporeal removal by haemodialysis or continuous haemofiltration, as neurological outcome depends on duration of exposure. Meanwhile, protein is stopped, high-rate 10% glucose limits catabolism, and ammonia scavengers (sodium benzoate, sodium phenylbutyrate) and arginine are given with metabolic specialist advice. References: British Inherited Metabolic Disease Group Emergency Guidelines: Hyperammonaemia.
Why not A: These target gut ammonia in liver failure and are ineffective for a urea cycle defect. Why not B: The baby is alkalotic, and bicarbonate does not lower ammonia. Why not C: Protein intake worsens the ammonia load, and delay risks permanent brain injury. Question 3 of 3 · Neurology and neurocritical care
Five days after aneurysmal subarachnoid haemorrhage, a 49-year-old man's sodium falls to 127 mmol/L. He has a high urine output, falling weight and a negative fluid balance; urine sodium is 120 mmol/L and urine osmolality 520 mOsm/kg. What is the most appropriate management?
Replace sodium and volume with saline, and consider fludrocortisone Restrict fluid to 1 L/day for presumed syndrome of inappropriate antidiuresis Start tolvaptan to promote free water excretion Give desmopressin to reduce his urine output Observe, as sodium above 125 mmol/L needs no treatment after SAH Show the answer A. Replace sodium and volume with saline, and consider fludrocortisone
Cerebral salt wasting causes natriuresis with true volume depletion, distinguishing it from the euvolaemic syndrome of inappropriate antidiuresis. After subarachnoid haemorrhage, fluid restriction is harmful whatever the cause because hypovolaemia promotes delayed cerebral ischaemia. Sodium and volume replacement, with fludrocortisone to reduce natriuresis, is the approach.
Why not B: Fluid restriction causes hypovolaemia, which increases the risk of delayed cerebral ischaemia. Why not C: Aquaresis would worsen his volume depletion. Why not D: Desmopressin would worsen hyponatraemia; he has natriuresis, not diabetes insipidus. Why not E: Hyponatraemia after SAH worsens cerebral oedema and should be corrected. Create a free account to save your results and keep going →
Where the CICM examiners flagged it Hot cases: missing or inventing signs, a rough or unfocused examination, weak synthesis and differentials, and needing prompts to commit to management. All CICM examiner reports →
Fellowship Ready is not affiliated with or endorsed by the CICM. Not affiliated with the CICM.